• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

益生菌和益生元的降胆固醇作用:体内和体外研究结果综述

Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.

作者信息

Ooi Lay-Gaik, Liong Min-Tze

机构信息

School of Industrial Technology, Universiti Sains Malaysia, 11800 Penang, Malaysia; E-Mail:

出版信息

Int J Mol Sci. 2010 Jun 17;11(6):2499-522. doi: 10.3390/ijms11062499.

DOI:10.3390/ijms11062499
PMID:20640165
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2904929/
Abstract

Probiotics are live microorganisms that promote health benefits upon consumption, while prebiotics are nondigestible food ingredients that selectively stimulate the growth of beneficial microorganisms in the gastrointestinal tract. Probiotics and/or prebiotics could be used as alternative supplements to exert health benefits, including cholesterol-lowering effects on humans. Past in vivo studies showed that the administration of probiotics and/or prebiotics are effective in improving lipid profiles, including the reduction of serum/plasma total cholesterol, LDL-cholesterol and triglycerides or increment of HDL-cholesterol. However, other past studies have also shown that probiotics and prebiotics had insignificant effects on lipid profiles, disputing the hypocholesterolemic claim. Additionally, little information is available on the effective dosage of probiotics and prebiotics needed to exert hypocholesterolemic effects. Probiotics and prebiotics have been suggested to reduce cholesterol via various mechanisms. However, more clinical evidence is needed to strengthen these proposals. Safety issues regarding probiotics and/or prebiotics have also been raised despite their long history of safe use. Although probiotic-mediated infections are rare, several cases of systemic infections caused by probiotics have been reported and the issue of antibiotic resistance has sparked much debate. Prebiotics, classified as food ingredients, are generally considered safe, but overconsumption could cause intestinal discomfort. Conscientious prescription of probiotics and/or prebiotics is crucial, especially when administering to specific high risk groups such as infants, the elderly and the immuno-compromised.

摘要

益生菌是食用后能促进健康益处的活微生物,而益生元是不可消化的食物成分,可选择性地刺激胃肠道中有益微生物的生长。益生菌和/或益生元可用作替代补充剂以发挥健康益处,包括对人类的降胆固醇作用。过去的体内研究表明,施用益生菌和/或益生元可有效改善血脂状况,包括降低血清/血浆总胆固醇、低密度脂蛋白胆固醇和甘油三酯,或提高高密度脂蛋白胆固醇。然而,其他过去的研究也表明,益生菌和益生元对血脂状况影响不显著,对降胆固醇的说法提出了质疑。此外,关于发挥降胆固醇作用所需的益生菌和益生元有效剂量的信息很少。有人提出益生菌和益生元可通过多种机制降低胆固醇。然而,需要更多临床证据来支持这些说法。尽管益生菌和/或益生元长期安全使用,但也引发了有关其安全性的问题。虽然益生菌介导的感染很少见,但已有几例由益生菌引起的全身感染病例报告,抗生素耐药性问题也引发了很多争论。益生元被归类为食物成分,通常被认为是安全的,但过量食用可能会引起肠道不适。谨慎开具益生菌和/或益生元的处方至关重要,尤其是在给婴儿、老年人和免疫功能低下等特定高危人群使用时。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8066/2904929/db736954f4f4/ijms-11-02499f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8066/2904929/7abc5327b608/ijms-11-02499f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8066/2904929/db736954f4f4/ijms-11-02499f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8066/2904929/7abc5327b608/ijms-11-02499f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8066/2904929/db736954f4f4/ijms-11-02499f2.jpg

相似文献

1
Cholesterol-lowering effects of probiotics and prebiotics: a review of in vivo and in vitro findings.益生菌和益生元的降胆固醇作用:体内和体外研究结果综述
Int J Mol Sci. 2010 Jun 17;11(6):2499-522. doi: 10.3390/ijms11062499.
2
Selection of potential probiotic lactobacilli for cholesterol-lowering properties and their effect on cholesterol metabolism in rats fed a high-lipid diet.选择具有降胆固醇特性的潜在益生菌乳杆菌及其对高脂饮食喂养大鼠胆固醇代谢的影响。
J Dairy Sci. 2012 Apr;95(4):1645-54. doi: 10.3168/jds.2011-4768.
3
Probiotics--interactions with bile acids and impact on cholesterol metabolism.益生菌——与胆汁酸的相互作用及其对胆固醇代谢的影响。
Appl Biochem Biotechnol. 2012 Dec;168(7):1880-95. doi: 10.1007/s12010-012-9904-4. Epub 2012 Oct 4.
4
Effects of consumption of probiotics and prebiotics on serum lipid levels in humans.食用益生菌和益生元对人体血清脂质水平的影响。
Crit Rev Biochem Mol Biol. 2002;37(4):259-81. doi: 10.1080/10409230290771519.
5
Prebiotics and lipid metabolism.益生元与脂质代谢。
Curr Opin Lipidol. 2002 Feb;13(1):61-7. doi: 10.1097/00041433-200202000-00009.
6
In vivo safety assessment of Lactobacillus fermentum strains, evaluation of their cholesterol-lowering ability and intestinal microbial modulation.Lactobacillus fermentum 菌株的体内安全性评估,降胆固醇能力及其对肠道微生物群的调节作用的评价。
J Sci Food Agric. 2020 Jan 30;100(2):705-713. doi: 10.1002/jsfa.10071. Epub 2019 Nov 9.
7
Probiotics and prebiotics in pediatrics.儿科中的益生菌和益生元。
Pediatrics. 2010 Dec;126(6):1217-31. doi: 10.1542/peds.2010-2548. Epub 2010 Nov 29.
8
Effects of probiotics, prebiotics, and synbiotics on polycystic ovary syndrome: a systematic review and meta-analysis.益生菌、益生元及合生元对多囊卵巢综合征的影响:一项系统评价与荟萃分析
Crit Rev Food Sci Nutr. 2023;63(4):522-538. doi: 10.1080/10408398.2021.1951155. Epub 2021 Jul 21.
9
The effect of probiotics, prebiotics or synbiotics on metabolic outcomes in individuals with diabetes: a systematic review and meta-analysis.益生菌、益生元或合生菌对糖尿病患者代谢结局的影响:系统评价和荟萃分析。
Diabetologia. 2021 Jan;64(1):26-41. doi: 10.1007/s00125-020-05295-1. Epub 2020 Oct 13.
10
The perspective on cholesterol-lowering mechanisms of probiotics.益生菌降胆固醇机制的研究视角
Mol Nutr Food Res. 2015 Jan;59(1):94-105. doi: 10.1002/mnfr.201400548.

引用本文的文献

1
Synbiotic Administration of d-Tagatose and ATCC 393 Improves Hyperlipidemia in BALB/c Mice by Modulating Gut Microbiota and Metabolic Parameters.d-塔格糖与ATCC 393的合生元给药通过调节肠道微生物群和代谢参数改善BALB/c小鼠的高脂血症。
Food Sci Nutr. 2025 Jul 10;13(7):e70597. doi: 10.1002/fsn3.70597. eCollection 2025 Jul.
2
Genomic and functional characterization of a strain isolated from human gut microbiota.从人类肠道微生物群中分离出的一株菌株的基因组和功能特征
mSystems. 2025 Aug 19;10(8):e0079025. doi: 10.1128/msystems.00790-25. Epub 2025 Jul 9.
3
Effects of Dietary High-Yield Protease Strain FRE76 on Broiler Growth, Slaughter Performance, Intestinal Morphology, and Gut Microbiota.

本文引用的文献

1
Resistant starch and cholestyramine have distinct effects on hepatic cholesterol metabolism in guinea pigs fed a hypercholesterolemic diet.抗性淀粉和消胆胺对喂食高胆固醇饮食的豚鼠肝脏胆固醇代谢有不同影响。
Nutr Res. 2000 Jun;20(6):837-849.
2
Effect on the cholesterol content of fresh lamb of supplementing the feed of Awassi ewes and lambs with Lactobacillus acidophilus.嗜酸乳杆菌补充阿瓦西母羊和羔羊饲料对新鲜羊肉胆固醇含量的影响。
Meat Sci. 1999 Aug;52(4):381-5. doi: 10.1016/s0309-1740(99)00017-0.
3
Removal of cholesterol by lactobacilli via incorporation and conversion to coprostanol.
日粮高产蛋白酶菌株FRE76对肉鸡生长性能、屠宰性能、肠道形态及肠道微生物群的影响
Animals (Basel). 2025 Apr 9;15(8):1085. doi: 10.3390/ani15081085.
4
Effects of on production performance and immunity of broiler chickens and their mechanism.[具体物质]对肉鸡生产性能和免疫力的影响及其机制。 (原文中“Effects of on...”这里“of”后面缺少具体内容)
Front Vet Sci. 2025 Mar 18;12:1554502. doi: 10.3389/fvets.2025.1554502. eCollection 2025.
5
Effect of JNU 534 Supplementation on the Performance, Blood Parameters and Meat Characteristics of Inoculated Broilers.添加JNU 534对感染肉鸡生产性能、血液参数及肉品质的影响
Microorganisms. 2025 Feb 27;13(3):525. doi: 10.3390/microorganisms13030525.
6
Review on the Function, Substrate Affinity, and Potential Application of Bile Salt Hydrolase Originated from Probiotic Strains of , , and .源自、和益生菌菌株的胆汁盐水解酶的功能、底物亲和力及潜在应用综述
Food Sci Anim Resour. 2025 Mar;45(2):353-374. doi: 10.5851/kosfa.2025.e1. Epub 2025 Mar 1.
7
Optimization of the cholesterol gallstone model in C57BL/6 mice and evaluation of Lactobacillus intervention effects.C57BL/6小鼠胆固醇胆结石模型的优化及乳酸杆菌干预效果评估。
BMC Gastroenterol. 2025 Feb 5;25(1):56. doi: 10.1186/s12876-025-03653-0.
8
Yogurt Supplementation Can Ameliorate Fatty Liver Diseases and Metabolic Syndrome in High Fat-Induced Conditions in Mice.补充酸奶可改善高脂诱导条件下小鼠的脂肪肝疾病和代谢综合征。
Food Sci Nutr. 2024 Dec 5;13(1):e4650. doi: 10.1002/fsn3.4650. eCollection 2025 Jan.
9
Effects of xylo-oligosaccharide supplementation on the production performance, intestinal morphology, cecal short-chain fatty acid levels, and gut microbiota of laying hens.低聚木糖添加对蛋鸡生产性能、肠道形态、盲肠短链脂肪酸水平及肠道微生物群的影响。
Poult Sci. 2024 Dec;103(12):104371. doi: 10.1016/j.psj.2024.104371. Epub 2024 Sep 30.
10
Invasions of Host-Associated Microbiome Networks.宿主相关微生物群落网络的入侵
Adv Ecol Res. 2017;57:201-281. doi: 10.1016/bs.aecr.2016.11.002.
通过将胆固醇掺入并转化为粪甾醇,乳酸菌将胆固醇去除。
J Dairy Sci. 2010 Apr;93(4):1383-92. doi: 10.3168/jds.2009-2574.
4
Angiotensin I-converting enzyme inhibitory activity and bioconversion of isoflavones by probiotics in soymilk supplemented with prebiotics.添加益生元的豆浆中益生菌对血管紧张素转化酶抑制活性和异黄酮的生物转化作用。
Int J Food Sci Nutr. 2010 Mar;61(2):161-81. doi: 10.3109/09637480903348122.
5
Transposon Tn917PF1 mutagenesis in Bacillus licheniformis.地衣芽孢杆菌中的转座子Tn917PF1诱变
Microbiology (Reading). 1994 Nov;140 ( Pt 11):3091-7. doi: 10.1099/13500872-140-11-3091.
6
Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice.植物乳杆菌 KCTC3928 通过增加 C57BL/6 小鼠胆汁酸排泄的降胆固醇作用。
Nutrition. 2010 Mar;26(3):321-30. doi: 10.1016/j.nut.2009.04.011. Epub 2009 Aug 19.
7
Safety evaluation of probiotic bifidobacteria by analysis of mucin degradation activity and translocation ability.通过分析黏蛋白降解活性和易位能力评估益生菌双歧杆菌的安全性。
Anaerobe. 2010 Apr;16(2):131-6. doi: 10.1016/j.anaerobe.2009.07.006. Epub 2009 Jul 26.
8
Dietary modulation of the human colonic microbiota: updating the concept of prebiotics.饮食调节人类结肠微生物群:更新益生元概念。
Nutr Res Rev. 2004 Dec;17(2):259-75. doi: 10.1079/NRR200479.
9
Modulation of the fecal microflora profile and immune function by a novel trans-galactooligosaccharide mixture (B-GOS) in healthy elderly volunteers.新型低聚半乳糖混合物(B-GOS)对健康老年志愿者粪便微生物群谱和免疫功能的调节作用
Am J Clin Nutr. 2008 Nov;88(5):1438-46. doi: 10.3945/ajcn.2008.26242.
10
Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp shermanii JS administered in capsules is ineffective in lowering serum lipids.鼠李糖乳杆菌LC705与谢氏丙酸杆菌JS以胶囊形式给药对降低血脂无效。
J Am Coll Nutr. 2008 Aug;27(4):441-7. doi: 10.1080/07315724.2008.10719723.